The Drug Enforcement Administration has issued a final rule that, effective July 6, permanently places 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever their existence is possible, in schedule I of the Controlled Substances Act.
This rule makes permanent the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances on persons who import, export, manufacture, distribute, possess, engage in research on, or conduct instructional activities with this substance, which include the following.
- any person who engages in the above activities with respect to this substance must be registered with the DEA to conduct such activities
- all importation and exportation of this substance must be in compliance with 21 USC 952, 953, 957, and 958 and in accordance with 21 CFR part 1312
- all labels and labeling for commercial containers of this substance must comply with the requirements of 21 CFR part 1302
- any activity involving this substance that is not authorized under the CSA or the Controlled Substances Import and Export Act is unlawful and potentially subject to criminal penalties
Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.